Breast Cancer

Right Breast Carcinoma

Female, 42 years

Patient Internal ID: 424408

ICD-10 code

C50.2 Malignant Neoplasm of Upper-inner Quadrant of Breast

Diagnosis (Incl. Metastases/Stage) and Year

April 2022
Right Breast Carcinoma pT1cN0M0 G3 ER(+), PR(-), HER2(-), LVI-1, R0, Ki67-60% Stage IA.

Previous Treatment

Surgery, Chemotherapy (Paclitaxel), Radiation Therapy, Hormone Therapy (Tamoxifen).

Prognosis and Survival Expectation

The prognosis for Localized Hormone Sensitive Breast Cancer is good, with a relative 5-year survival rate up to 95%.

Treatment Provided

Autologous DCV (7 doses) and CIK (8 doses) over a period of 9 months. Additionally, the patient received Immunostimulation of Interferon (IFN) β and Tumor Necrosis Factor (TNF) as well as Mistletoe Therapy.

Patient Survival/Condition and Year
Date of Review: 25/11/2023

The patient is alive, has a stable disease and no sign of disease progression. She continues hormonal treatment with Tamoxifen and is attending regular check-ups.